Luminist Capital’s iShares Biotechnology ETF IBB Stock Holding History

Luminist Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$675	–	182
2025 Q4	$675	Hold	4	–	–	﹤0.01%	253
2025 Q3	$594	Hold	4	–	–	﹤0.01%	309
2025 Q2	$511	Hold	4	–	–	﹤0.01%	313
2025 Q1	$498	Hold	4	–	–	﹤0.01%	232
2024 Q4	$529	Buy	+4	New	+$562	﹤0.01%	221

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Luminist Capital's IBB Position: Q1 2026 in Review

Luminist Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 4 shares — an estimated $675 sold.

Luminist Capital first reported a position in IBB in Q4 2024 and held it in 5 quarters. The position peaked at $675 in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Luminist Capital reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Luminist Capital sold 4 iShares Biotechnology ETF shares in Q1 2026, an estimated $675.
Luminist Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 5 quarters.
Luminist Capital's iShares Biotechnology ETF position peaked at $675 in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Luminist Capital's 13F filing for Q1 2026, filed 24 Apr 2026.